Sign in
Taking peopleNo phase

Diagnostic of D-lactate in Cerebrospinal Fluid Level in Patients With Suspected Ventriculostomy-related Meningitis

Key facts

Who runs it
University Hospital, Toulouse
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
185 people, planned
Started
12 Feb 2025
Expected to end
Feb 2027
Type of study
Interventional, 2 groups
Treatments tested
  • CSF sample
Record updated
31 December 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Age ⩾ 18 years
  • Patient with an external ventriculostomy implanted at the Toulouse University Hospital
  • Patient suspected of nosocomial meningitis due to a febrile syndrome (in the absence of any other identified infectious site), headache, nausea, lethargy, change in neurological status, meningeal syndrome, epileptic event and cutaneous or subcutaneous inflammation at the ventriculostomy site of insertion
  • Patient having expressed oral consent, after free and informed information
  • Patient affiliated to a social security scheme

Who cannot take part

  • Proven or suspected meningitis and/or ventriculitis during the previous month
  • Diagnosis of nosocomial meningitis made in another medical centre prior to admission
  • Short bowel syndrome
  • End-stage renal failure (GFR < 15 ml/min/m2)
  • Diagnosis of community meningitis
  • Acute mesenteric ischaemia
  • Peritoneal dialysis
  • Patient participating in another research protocol with an exclusion period still in progress
  • Pregnant or breastfeeding woman
  • Patient under guardianship or trusteeship, persons placed under the protection of justice

This trial is currently available in France.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The TOTEM study is a single-center study designed to evaluate the performance of the D-lactate assay in cerebrospinal fluid (CSF) for the diagnosis of ventriculostomy-related nosocomial meningitis. The study will be conducted in the neurosurgical intensive care unit of the Toulouse University Hospital, in patients with a suspected diagnosis of ventriculostomy-related nosocomial meningitis.

The 2 groups in the trial

  • Ventriculostomy-related nosocomial meningitisTreatment being tested

    Finally, two neurosurgical reanimators will retrospectively diagnose nosocomial meningitis, or the absence of meningitis, according to the information from the patient's medical records.

    Treatment: CSF sample

  • Absence of nosocomial meningitisOther group

    Finally, two neurosurgical reanimators will retrospectively diagnose nosocomial meningitis, or the absence of meningitis, according to the information from the patient's medical records.

    Treatment: CSF sample

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Diagnostic Significance of D-lactate in Cerebrospinal Fluid Level in Patients With Suspected Ventriculostomy-related Meningitis : a Pilot Study
Record updated
31 December 2025